跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-CLOBETASOL SPRAY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-CLOBETASOL SPRAY
Authorized
STANDARD
TARO-CLOBETASOL SPRAY
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
366908ced874501b
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
366908ced874501b
Drug Approval Canada Name
TARO-CLOBETASOL SPRAY
Product Name
TARO-CLOBETASOL SPRAY
Status
Marketed
Status Date
2019-08-26
Original Market Date
2019-08-26
Din
02489619
Drug Class
Human
Dosage Form
Spray
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:06.00
Atc Original
D07AD01 CLOBETASOL
Atc Name
d 07 ad 01
Aig Number
0110995001
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive, Brampton, Ontario, Canada, L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
CLOBETASOL PROPIONATE
0.05 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
366908ced874501b
Type
Standard
Back to Health Canada Approvals